1
2
Jacobs, M S, van Leent, M W J, Tieleman, R G, Jansman, F G A, Cao, Q, Postma, M J, van Hulst, M
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017